MR1 expression and surface translocation in airway epithelial cells from COPD or smoker lungs is altered following exposure to IFNγ or MAIT cells.

Abstract

Abstract MAIT cells, a highly prevalent subset of T cells restricted by the MHC Class I-like molecule MR1, play a key role in early response to bacterial infection. Chronic obstructive pulmonary disease (COPD) pathogenesis is associated with airway inflammation, increased infiltration by CD8+ T lymphocytes, and infection-driven exacerbations. Cigarette smoke (CS), a leading cause of COPD, leads to impaired immune function of airway epithelial cells (AECs) and decreases surface expression of classical MHC Class I molecules. However, the impact of CS and COPD on MR1 expression and airway MAIT cell function is unknown. We have demonstrated that exposure to CS alters MAIT cell responses to primary AECs from healthy, COPD, or smoker lungs. Here, we examined whether CS impacts expression of MR1 mRNA or surface translocation of MR1 in these primary AEC populations as a possible mechanism for this dysregulation. Short-term treatment of AECs with CS or infection with S. pneumoniae (SP) did not alter MR1 expression in any of the donor AEC groups. However, incubating CS-treated or SP-infected AECs with MAIT cells increased MR1 expression. This upregulation may be mediated through IFNγ signaling pathways, as treatment with IFNγ alone resulted in MR1 upregulation. Our data further suggest MAIT cell- and IFNγ-mediated MR1 upregulation is altered in COPD cells. Additionally, we observed increased baseline surface expression of MR1 protein in smoker AECs and reduced surface translocation upon addition of exogenous ligand. COPD- and CS-mediated dysregulation of MR1 expression could impact MAIT cell function in airways, resulting in inflammation or reduced early response to bacteria, contributing to lower airway colonization and COPD exacerbations.